DK0509402T3 - Substituerede 3-(pyridinylamino)-indoler og benzol og anvendelse som lægemidler - Google Patents

Substituerede 3-(pyridinylamino)-indoler og benzol og anvendelse som lægemidler

Info

Publication number
DK0509402T3
DK0509402T3 DK92106162T DK92106162T DK0509402T3 DK 0509402 T3 DK0509402 T3 DK 0509402T3 DK 92106162 T DK92106162 T DK 92106162T DK 92106162 T DK92106162 T DK 92106162T DK 0509402 T3 DK0509402 T3 DK 0509402T3
Authority
DK
Denmark
Prior art keywords
loweralkyl
hydrogen
chem
arylloweralkyl
halogen
Prior art date
Application number
DK92106162T
Other languages
Danish (da)
English (en)
Inventor
Richard Charles Effland
Joseph Thomas Klein
Lawrence Leo Martin
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of DK0509402T3 publication Critical patent/DK0509402T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK92106162T 1991-04-17 1992-04-09 Substituerede 3-(pyridinylamino)-indoler og benzol og anvendelse som lægemidler DK0509402T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/688,964 US5177088A (en) 1991-04-17 1991-04-17 Substituted 3-(pyridinylamino)-indoles

Publications (1)

Publication Number Publication Date
DK0509402T3 true DK0509402T3 (da) 1998-09-07

Family

ID=24766519

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92106162T DK0509402T3 (da) 1991-04-17 1992-04-09 Substituerede 3-(pyridinylamino)-indoler og benzol og anvendelse som lægemidler

Country Status (25)

Country Link
US (1) US5177088A (no)
EP (1) EP0509402B1 (no)
JP (1) JP2617650B2 (no)
KR (1) KR100254027B1 (no)
AT (1) ATE161840T1 (no)
AU (1) AU655253B2 (no)
BG (1) BG61034B1 (no)
CA (1) CA2066332C (no)
CS (1) CS117192A3 (no)
DE (1) DE69223837T2 (no)
DK (1) DK0509402T3 (no)
ES (1) ES2111580T3 (no)
FI (1) FI105096B (no)
GR (1) GR3026317T3 (no)
HU (1) HU215113B (no)
IE (1) IE921235A1 (no)
IL (1) IL101599A (no)
MX (1) MX9201759A (no)
NO (1) NO180486C (no)
NZ (1) NZ242359A (no)
PL (1) PL168905B1 (no)
RO (1) RO109847B1 (no)
RU (1) RU2060254C1 (no)
TW (1) TW200477B (no)
ZA (1) ZA922807B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264442A (en) * 1990-08-13 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5185350A (en) * 1991-09-23 1993-02-09 Hoechst-Roussel Pharmaceuticals Incorporated Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles
US5356910A (en) 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder
WO1996039397A1 (en) * 1995-06-06 1996-12-12 Hoechst Marion Roussel, Inc. Benzisoxazole and indazole derivatives as antipsychotic agents
US5668154A (en) * 1995-06-06 1997-09-16 Hoechst Marion Roussel Inc. Pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles
DE69715668T2 (de) * 1996-12-27 2003-07-31 Aventis Pharma Inc N-(pyridinylamino)isoindoline und verwandte verbindungen
CA2383332C (en) * 1999-09-14 2006-01-10 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists
US7253165B2 (en) * 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
DE10029371A1 (de) 2000-06-20 2002-01-03 Merck Patent Gmbh Heterocyclische Aminoalkylpyridinderivate als Psychopharmaka
GB0217920D0 (en) * 2002-04-23 2002-09-11 Aventis Pharm Prod Inc Interleukin-4 Gene Expression inhibitors
CN1993321A (zh) 2004-06-01 2007-07-04 弗·哈夫曼-拉罗切有限公司 作为单胺再摄取抑制剂的3-氨基-1-芳基丙基吲哚类化合物
EP2351737A1 (en) * 2005-11-30 2011-08-03 F. Hoffmann-La Roche AG 3-Amino-1-arylpropyl indoles and aza-substituted indoles
ES2329413T3 (es) 2005-11-30 2009-11-25 F. Hoffmann-La Roche Ag 3-amino-2-arilpropil azaindoles y usos de los mismos.
KR20080072753A (ko) * 2005-11-30 2008-08-06 에프. 호프만-라 로슈 아게 3-아미노-1-아릴프로필 인돌 및 아자-치환된 인돌
CN101952281B (zh) * 2008-01-04 2014-04-02 株式会社Lg生命科学 具有细胞、组织及器官保存效果的吲哚及吲唑衍生物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3166987D1 (en) * 1980-09-18 1984-12-06 Asahi Chemical Ind 3-aminoindazole derivatives and process for preparation thereof
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
US4717658A (en) * 1985-12-03 1988-01-05 Miles Inc. Gram negative bacteria screening method with horseshoe crab amebocyte lysate (LAL)
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
US4806554A (en) * 1988-01-11 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. Pyrazol and indazolpyridinamines
US4954502A (en) * 1988-06-10 1990-09-04 Bristol-Myers Squibb Company 1-indolyalkyl-4-(substituted-pyridinyl)piperazines
ES2076253T3 (es) * 1989-05-19 1995-11-01 Hoechst Roussel Pharma N-(ariloxialquil)-heteroarilpiperidinas y -heteroarilpiperazinas, un procedimiento para su preparacion y su uso como medicamentos.
US4983615A (en) * 1989-06-28 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles
CA2030051C (en) * 1989-11-17 2001-08-07 Haruhiko Kikuchi Indole derivatives

Also Published As

Publication number Publication date
TW200477B (no) 1993-02-21
NO921505D0 (no) 1992-04-15
IL101599A0 (en) 1992-12-30
KR100254027B1 (ko) 2000-05-01
NZ242359A (en) 1995-03-28
ES2111580T3 (es) 1998-03-16
DE69223837D1 (de) 1998-02-12
IL101599A (en) 1996-05-14
ATE161840T1 (de) 1998-01-15
AU655253B2 (en) 1994-12-08
US5177088A (en) 1993-01-05
RU2060254C1 (ru) 1996-05-20
HUT62572A (en) 1993-05-28
CS117192A3 (en) 1992-11-18
GR3026317T3 (en) 1998-06-30
DE69223837T2 (de) 1998-06-25
JPH05117266A (ja) 1993-05-14
HU215113B (hu) 1998-12-28
FI921693A (fi) 1992-10-18
PL168905B1 (pl) 1996-05-31
RO109847B1 (ro) 1995-06-30
NO180486C (no) 1997-04-30
BG61034B1 (bg) 1996-09-30
AU1512192A (en) 1992-10-22
JP2617650B2 (ja) 1997-06-04
NO180486B (no) 1997-01-20
ZA922807B (en) 1992-11-25
IE921235A1 (en) 1992-10-21
EP0509402B1 (en) 1998-01-07
NO921505L (no) 1992-10-19
CA2066332C (en) 2003-07-29
CA2066332A1 (en) 1992-10-18
PL294239A1 (en) 1993-06-14
FI105096B (fi) 2000-06-15
MX9201759A (es) 1992-10-01
EP0509402A1 (en) 1992-10-21
FI921693A0 (fi) 1992-04-15
KR920019777A (ko) 1992-11-20
HU9201297D0 (en) 1992-07-28

Similar Documents

Publication Publication Date Title
DK0509402T3 (da) Substituerede 3-(pyridinylamino)-indoler og benzol og anvendelse som lægemidler
BR1100534A (pt) Carbamatos substituìdos de 1-(piridilamino substituìdo) -1h-indol-5-ila
FI934611A (fi) Substituerade (pyridinylamino)-bensisoxazoler och -benso(b)tiofener, foerfarande foer framstaellning av dessa och anvaendning av dessa som laekemedel
FI924230A (fi) Substituerade pyridinylamino-1h-indoler, -1h-indazoler, -2h-indazoler,-benso(b)tiofener och -1,2-bensoisotiazoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
DE69114404D1 (de) 1-(Pyridinylalkyl)-1H-indole, -indoline und Analoge.
DK0534344T3 (da) Substituerede 3-amino-2,3,4,5-tetrahydro-1-aryl-oxy-3-benzazepiner, fremgangsmåde til deres fremstilling og deres anvendelse som modulatorer af neurotransmitterfunktionen
ATE129710T1 (de) Carbamoyl-1-(pyridinylalkyl)-1h-indole, -indoline und verwandte verbindungen.